Navigation Links
PNAS Publishes Preclinical Results of EntreMed's 2ME2 for Multiple Sclerosis
Date:12/4/2012

tiated a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer.  Its second compound, 2ME2, has been investigated in clinical trials in oncology patients, and is the subject of a successful IND filing for clinical use to treat RA.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

Forward Looking Statements           

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under development; results in precli
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
2. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
3. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
4. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
5. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
8. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
9. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
10. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
11. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... China Biologic Products, Inc. (NASDAQ: CBPO, "China ... biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2014 Financial Highlights ... increased by 36.2%, or 36.8% excluding the impact of ... $42.6 million in the same quarter of 2013. ...
(Date:3/4/2015)... 4, 2015 GSI Group Inc. (NASDAQ: ... global leader and supplier of precision photonics and motion ... advanced industrial technology markets, today reported financial results for ... noted, all financial results in this press release are ... QuarterDuring the fourth quarter of 2014, GSI generated revenue ...
(Date:3/4/2015)... March 4, 2015 Alimera Sciences, Inc. ... company that specializes in the research, development and ... results for the fourth quarter and year ended ... was a pivotal year for Alimera Sciences, most ... in September for the treatment of diabetic macular ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15
... to unblocking heart arteries minimally invasively will mean less ... overall, particularly for obese patients, according to data being ... Therapy (ISET). Every year, about one million Americans opt ... arteries. New data suggests that beginning the angioplasty procedure ...
... international,investment house specialising in medical sciences, said today ... stem cell treatments if it is,to remain at ... Professor Sir Christopher Evans, founder and ... has received approval from the UK,Medicines and Healthcare ...
Cached Medicine Technology:Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries 2UK Must Maintain its Momentum in Stem Cell Expertise 2
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
(Date:3/4/2015)... 2015 Vancouver chiropractic clinic, Backs ... awards in the prestigious Vancouver Courier “Stars of ... 2015. The company secured third place in the ... “Best Registered Massage Therapist” category. , As ... Canada, The Vancouver Courier is a semiweekly local ...
(Date:3/4/2015)... As seen on Advanced Fertility Center ... a painful condition in which the lining of the ... leading to very unpleasant symptoms and complications that greatly ... terrible effect on women’s quality of life due to ... cause of infertility in women and carries a huge ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The ... downstream client survey, marketing channels, industry development trend ... of the industry, including spices definitions, applications and ... domestic market analysis are provided with a focus ... the market. A comparison between the international and ...
(Date:3/4/2015)... 04, 2015 Plungerhead has ... service members during and after their service to the ... increase awareness through advertising, social media and several national ... patriotic organization through a special retail promotion of Plungerhead ... March through May 2015. , “There is a ...
Breaking Medicine News(10 mins):Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3
... RESEARCH TRIANGLE PARK, N.C. , March 23 ... nursing instructors at North Carolina public and ... Educators of Tomorrow (NET) scholarship-loan for the 2010-11 academic ... 80 new awards are available for the coming year, ...
... future might help you feel better for real. In ... University of Kentucky and Sandra Sephton of the University ... future affected their immune response. Their conclusions: Optimism may ... found that people who are optimistic about their health ...
... population aging is "transforming the world." Now that a large ... the "baby boomers," the phenomenon is permeating many areas of ... the U.S., as of 2008 (the last time data was ... 38.9 million. The Administration on Aging predicts that by 2030, ...
... the blood linked to alcohol use may potentially lead to ... to Penn State College of Medicine researchers. "The ... things like cocaine or heroin or PCP -- is that ... said Willard M. Freeman, Ph.D., department of pharmacology and lead ...
... ... , ... (PRWEB) March 23, 2010 -- Outbreaks of foodborne illness are on the increase, affecting ... suggests that foodborne illness kill 5,000 Americans and cost $152 billion per year. To ...
... ... announce the current time aloud when it hears a noise. , ... (PRWEB) March 23, 2010 -- The recently released ,Wake Up Now? - ... nights rest. The first thing one thinks when awaking before the alarm sounds is, "How much ...
Cached Medicine News:Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 2Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 3Health News:Nurse Educator of Tomorrow Scholarship Applications Are Now Available 4Health News:Optimism boosts the immune system 2Health News:The longevity revolution 2Health News:Proteins may point to alcohol use test 2Health News:Proteins may point to alcohol use test 3Health News:Louisiana Law Firm Neblett, Beard & Arsenault Launches New Foodborne Illness Site 2Health News:Louisiana Law Firm Neblett, Beard & Arsenault Launches New Foodborne Illness Site 3Health News:Excelltech's New iPhone Alarm Clock App Announces Time When Asked 2
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
Lachrymal cannula, straight....
The first easy-to use peroxide system offers proven efficacy that's pure and simple. The convenience of a multi-purpose cleaner/rinse in one bottle. Added power of peroxide in the other bottle....
Angled shaft with 0.2 tip, round serrated handle, dull finish, overall length 130 mm...
Medicine Products: